ArticleDiscover nano2026
Novel phase-controlled Al
Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, alumina/iron oxide nanocomposites are synthesized via a simple, cost-effective co-precipitation method and investigated for the removal of copper ions from acidic aqueous media. Five samples with varying iron oxide phase contents are prepared by varying the precursor molar ratios. Structural analysis confirms the coexistence of Al₂.₆₆O₃.₉₉ and iron oxide phases, while Rietveld refinement reveals that the iron oxide phase fraction increases from 0.2% to 67.2% across the synthesized samples. The nanocomposites are characterized in detail using a range of analytical methods, including structural, morphological, optical, magnetic, and elemental analyses. Magnetic measurements indicate soft-magnetic behavior, with an enhanced response observed in the sample with the highest iron oxide content. The experimental results demonstrate rapid uptake of Cu(II), with significant removal occurring within the first few minutes and removal efficiencies exceeding 90% after 90 min for most samples. Nonlinear kinetic analysis indicates that the pseudo-second-order model provides a good description of Cu(II) adsorption behavior, while complementary characterization elucidates the underlying adsorption interactions. Owing to their tunable phase composition and effective Cu(II) adsorption performance, these alumina/iron oxide nanocomposites show potential for wastewater treatment in mildly acidic aqueous media.Clinical trial number: Not Applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.